National Institutes of Health (NIH) scientists and their colleagues report that a single dose of a broadly neutralizing antibody (bnAb) administered prior to virus exposure protects macaques from ...

Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

Researchers have demonstrated, for the first time in the world using mice, the ability to overcome significant challenges in ...

Researchers have a new hope for preventing severe illness from the bird flu after finding a groundbreaking antibody treatment ...

尽管如此，本研究为 65 岁以上老年人接种三种基于蛋白的含 XBB 疫苗后的中和抗体反应提供了重要证据，为优化老年人群疫苗接种策略、增强对新兴 SARS-CoV-2 变体的中和免疫力提供了关键信息。未来需进一步研究不同给药途径疫苗诱导的免疫特征、年龄对加强免疫后免疫力持久性的影响以及疫苗对新变体的效力等问题，以更好地应对新冠疫情，保障老年人群健康。

Moving forward, the team is trying to understand “how the antibody response changes after multiple diverse exposures to SARS-CoV-2 to inform how to elicit broadly neutralizing antibodies by ...

A new antibody therapy effectively protects monkeys from severe H5N1 avian flu, offering hope for a universal flu vaccine and ...

A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

National Institutes of Health (NIH) scientists and their colleagues report that a single dose of a broadly neutralizing ...

Scientists at the University of Pittsburgh have tested a broadly neutralizing antibody (bnAb) that binds the stem of a protein against H5N1 avian influenza, which prevented severe disease in nonhuman ...

The highly pathogenic avian influenza H5N1 infection has killed millions of birds around the world, and has spread to humans ...

In total, 5% of dogs and 13% of cats tested positive for COVID-19 on polymerase chain reaction, and 25% and 36%, respectively ...